The approval rate for new drugs has been cut in half from previous years, according to a February study conducted by the Biotechnology Industry Organization and BioMedTracker. More than 4,000 drugs were part of the study, which involved data from 2004 to 2010 and found a success rate of one in 10 from Phase I […]
In January, the FDA announced a plan to improve the 510(k) program. The plan includes 25 actions the FDA’s Center for Devices and Radiological Health (CDRH) intends to take this year, including new guidance and improved staff training. Among the actions are the issuance of new guidance on 510(k) modifications by June 15. The plan […]
Endowments at 850 US colleges, universities and affiliated foundations that participated in a 2010 study of endowments gained 11.9% for the year ending June 30, 2010, a significant improvement over the average loss of 18.7% reported in the previous year’s study. The average annual return over a three-year period was a decline of 4.2%. The […]
The US EPA plans to establish the first national standard for perchlorate by proposing a formal rule. The decision, which reverses one by the Bush Administration, was made after EPA scientists’ research on the naturally occurring and man-made chemical raised concerns about potential adverse effects it may have on the thyroid. In addition to setting […]
Commissioned by GE and managed by StrategyOne, the GE Global Innovation Barometer surveyed 1,000 executives in 12 countries, who are involved with their companies’ innovation processes. Among respondents, 95% agreed that innovation was the main component of a more competitive national economy. Eighty-eight percent indicated that the best way to create jobs in their country […]
According to Gartner, global semiconductor capital equipment spending was set to approach $38.4 billion in 2010, a 131.2% increase from 2009. In 2011, spending will decline 1.0% to $38.0 billion due to the shifted focus from technology equipment to capacity for equipment purchases. Gartner predicts that capital spending will be affected by two major trends: […]
Sixty-six percent of managers involved with plant and company operations who responded to Food Processing’s tenth annual Manufacturing Trends Survey were optimistic about 2011, similar to last year’s results. Fifty-seven percent of the 425 respondents listed food safety as their primary concern. Seventy-five percent employed new food safety measures in 2010, and 73% plan to […]
Chemicals The chemical industry bounced back in 2010, as Asian demand and higher prices led to decreased capacity and higher profitability. According to the American Chemical Council (ACC), chemical production volumes improved 8.8% last year (see IBO 12/15/10), driven by a 12.2% increase in emerging markets. Oxford Economics estimates worldwide production of chemicals and man-made […]
In each year’s forecast issue, IBO takes a look back at the events of the previous year and the trends that emerged. The list is presented in no particular order. Recovery Last year was a year of recovery for analytical instrument and laboratory product sales. On the heels of the global economic upturn, instrument sales […]
Following a deal with states and environmental organizations, the US EPA plans to set New Source Performance Standards (NSPS) on greenhouse gas emissions from power plants and refineries, which account for 40% of such emissions. The EPA’s current greenhouse gas regulations, which take effect January 2, 2011, focus on energy efficiency and apply to cars, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
